Management of Acute Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Utilizing Amniotic Membrane and Topical Corticosteroids

American Journal of Ophthalmology

Volumn 149, Issue 2, 2010, Pages

  Shammas, Maya C ^a   Lai, Edward C ^a   Sarkar, Jayati S ^a   Yang, Jennifer ^a   Starr, Christopher E ^a   Sippel, Kimberly C ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BACITRACIN; BOIS DE ROSE OIL; CORTICOSTEROID; CYCLOSPORIN; CYCLOSPORIN A; FLUCONAZOLE; FLUOROMETHOLONE; IBUPROFEN; LAMOTRIGINE; MOXIFLOXACIN; NABUMETONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; UNCLASSIFIED DRUG; VEGETABLE OIL;

ADULT; AGED; AMNION; ARTICLE; CHILD; CLINICAL ARTICLE; CORNEA PERFORATION; DISEASE COURSE; EYE DISEASE; FEMALE; FOLLOW UP; HUMAN; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLIT LAMP; STEROID THERAPY; STEVENS JOHNSON SYNDROME; SURGICAL TECHNIQUE; TOXIC EPIDERMAL NECROLYSIS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 73549120164     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2009.08.040     Document Type: Article

References (36)

1. Roujeau J.C. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J Invest Dermatol 102 (1994) 28S-30S
2. Roujeau J.C., and Stern R.S. Severe adverse cutaneous reactions to drugs. N Engl J Med 331 (1994) 1272-1285
3. Power W.J., Ghoraishi M., Merayo-Lloves J., Neves R.A., and Foster C.S. Analysis of the acute ophthalmic manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis disease spectrum. Ophthalmology 102 (1995) 1669-1676
4. Chang Y.S., Huang F.C., Tseng S.H., Hsu C.K., Ho C.L., and Sheu H.M. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management. Cornea 26 (2007) 123-129
5. De Rojas M.V., Dart J.K., and Saw V.P. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy. Br J Ophthalmol 91 (2007) 1048-1053
6. Haber J., Hopman W., Gomez M., and Cartotto R. Late outcomes in adult survivors of toxic epidermal necrolysis after treatment in a burn center. J Burn Care Rehabil 26 (2005) 33-41
7. Yip L.W., Thong B.Y., Lim J., et al. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series. Allergy 62 (2007) 527-531
8. Mondino B.J. Cicatricial pemphigoid and erythema multiforme. Ophthalmology 97 (1990) 939-952
9. Hynes A.Y., Kafkala C., Daoud Y.J., and Foster C.S. Controversy in the use of high-dose systemic steroids in the acute care of patients with Stevens-Johnson syndrome. Int Ophthalmol Clin 45 (2005) 25-48
10. Letko E., Papaliodis D.N., Papaliodis G.N., Daoud Y.J., Ahmed A.R., and Foster C.S. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann Allergy Asthma Immunol 94 (2005) 419-436 quiz 436-438, 456
11. Arstikaitis M.J. Ocular aftermath of Stevens-Johnson syndrome. Arch Ophthalmol 90 (1973) 376-379
12. Howard G.M. The Stevens-Johnson syndrome. Ocular prognosis and treatment. Am J Ophthalmol 55 (1963) 893-900
13. Lehman S.S. Long-term ocular complication of Stevens-Johnson syndrome. Clin Pediatr (Phila) 38 (1999) 425-427
14. Wright P., and Collin J.R. The ocular complications of erythema multiforme (Stevens Johnson syndrome) and their management. Trans Ophthalmol Soc U K 103 Pt 3 (1983) 338-341
15. Honavar S.G., Bansal A.K., Sangwan V.S., and Rao G.N. Amniotic membrane transplantation for ocular surface reconstruction in Stevens-Johnson syndrome. Ophthalmology 107 (2000) 975-979
16. Tseng S.C., Prabhasawat P., Barton K., Gray T., and Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116 (1998) 431-441
17. Tsubota K., Satake Y., Ohyama M., et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 122 (1996) 38-52
18. Solomon A., Espana E.M., and Tseng S.C. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 110 (2003) 93-100
19. Di Pascuale M.A., Espana E.M., Liu D.T., et al. Correlation of corneal complications with eyelid cicatricial pathologies in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis syndrome. Ophthalmology 112 (2005) 904-912
20. Gregory D.G. The ophthalmologic management of acute Stevens-Johnson syndrome. Ocul Surf 6 (2008) 87-95
21. John T., Foulks G.N., John M.E., Cheng K., and Hu D. Amniotic membrane in the surgical management of acute toxic epidermal necrolysis. Ophthalmology 109 (2002) 351-360
22. Kobayashi A., Yoshita T., Sugiyama K., et al. Amniotic membrane transplantation in acute phase of toxic epidermal necrolysis with severe corneal involvement. Ophthalmology 113 (2006) 126-132
23. Muqit M.M., Ellingham R.B., and Daniel C. Technique of amniotic membrane transplant dressing in the management of acute Stevens-Johnson syndrome. Br J Ophthalmol 91 (2007) 1536
24. Tandon A., Cackett P., Mulvihill A., and Fleck B. Amniotic membrane grafting for conjunctival and lid surface disease in the acute phase of toxic epidermal necrolysis. J AAPOS 11 (2007) 612-613
25. Araki Y., Sotozono C., Inatomi T., et al. Successful treatment of Stevens-Johnson syndrome with steroid pulse therapy at disease onset. Am J Ophthalmol 147 (2009) 1004-1011
26. Sotozono C., Ueta M., Koizumi N., et al. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications. Ophthalmology 116 (2009) 685-690
27. Magina S., Lisboa C., Leal V., Palmares J., and Mesquita-Guimaraes J. Dermatological and ophthalmological sequels in toxic epidermal necrolysis. Dermatology 207 (2003) 33-36
28. Sheridan R.L., Schulz J.T., Ryan C.M., et al. Long-term consequences of toxic epidermal necrolysis in children. Pediatrics 109 (2002) 74-78
29. Oplatek A., Brown K., Sen S., Halerz M., Supple K., and Gamelli R.L. Long-term follow-up of patients treated for toxic epidermal necrolysis. J Burn Care Res 27 (2006) 26-33
30. Samson C.M., Nduaguba C., Baltatzis S., and Foster C.S. Limbal stem cell transplantation in chronic inflammatory eye disease. Ophthalmology 109 (2002) 862-868
31. Tugal-Tutkun I., Akova Y.A., and Foster C.S. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 102 (1995) 576-585
32. Solomon A., Ellies P., Anderson D.F., et al. Long-term outcome of keratolimbal allograft with or without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 109 (2002) 1159-1166
33. Gomes J.A., Romano A., Santos M.S., and Dua H.S. Amniotic membrane use in ophthalmology. Curr Opin Ophthalmol 16 (2005) 233-240
34. Tseng S.C., Espana E.M., Kawakita T., et al. How does amniotic membrane work?. Ocul Surf 2 (2004) 177-187
35. Lee S.H., and Tseng S.C. Amniotic membrane transplantation for persistent epithelial defects with ulceration. Am J Ophthalmol 123 (1997) 303-312
36. Letko E., Stechschulte S.U., Kenyon K.R., et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol 119 (2001) 659-663